SCHABER CHRISTOPHER J
Transaction: 12/11/2025
BUY
Change
+200,000
Price
$1.63
Filing
12/12/2025
Type
BUY
Soligenix, Inc.
SNGX • Biotechnology
$0.38
▼ -0.00 (-0.84%)
Current price
EarningsLatest report: Jun 30, 2026
BALANCED PROFILENeutralConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$6.06M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Positive revenue growth · 676.8%Manageable debt level · 0.07Healthy liquidity · 2.39Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 1:11 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.38
Change-0.84%
Shares Out15.95M
Market Cap$6.06M
Enterprise Value$-3.45M
52W Range0.28 - 6.23
Beta1.92
P/E-0.73
P/B0.91
P/FCF-0.62
EV/EBITDA0.31
EV/FCF0.35
Price$0.38
Change-0.84%
Shares Out15.95M
Market Cap$6.06M
Enterprise Value$-3.45M
52W Range0.28 - 6.23
Beta1.92
P/E-0.73
P/B0.91
P/FCF-0.62
EV/EBITDA0.31
EV/FCF0.35
Earnings Yield-136.13%
FCF Yield-160.66%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.07
Current Ratio2.39
Quick Ratio2.39
Volume127.44K
Avg Volume7.37M
EPS Surprise0.02
Investment DNA
How strong this company looks for long-term investors
56
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
94/100
Why this score▼
Positive revenue growth · 676.8%Manageable debt level · 0.07Healthy liquidity · 2.39Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 8 analyst votes · 2026-09-05
81/100
Bullish
Bullish
5
Hold
3
Bearish
0
Insider Transactions
Recent executive and insider activity
Guarino Jonathan L.
Transaction: 12/11/2025
BUY
Change
+100,000
Price
$1.63
Filing
12/12/2025
Type
BUY
Donini Oreola
Transaction: 12/11/2025
BUY
Change
+100,000
Price
$1.63
Filing
12/12/2025
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| SCHABER CHRISTOPHER J | BUY | +200,000 | $1.63 | 12/11/2025 | 12/12/2025 |
| Guarino Jonathan L. | BUY | +100,000 | $1.63 | 12/11/2025 | 12/12/2025 |
| Donini Oreola | BUY | +100,000 | $1.63 | 12/11/2025 | 12/12/2025 |
| Straube Richard | BUY | +10,000 | $1.63 | 12/11/2025 | 12/12/2025 |
| SCHABER CHRISTOPHER J | BUY | +15,132 | $1.32 | 10/02/2025 | 10/03/2025 |
| Parks Diane L. | BUY | +17,647 | $1.70 | 06/20/2025 | 06/20/2025 |
| RUBIN ROBERT J. | BUY | +17,647 | $1.70 | 06/20/2025 | 06/20/2025 |
| ZELDIS JEROME B | BUY | +17,647 | $1.70 | 06/20/2025 | 06/20/2025 |
| LAPOINTE ANTHONY GREGG | BUY | +17,647 | $1.70 | 06/20/2025 | 06/20/2025 |
| RUBIN ROBERT J. | BUY | +8,646 | $3.47 | 12/12/2024 | 12/13/2024 |
| ZELDIS JEROME B | BUY | +8,646 | $3.47 | 12/12/2024 | 12/13/2024 |
| LAPOINTE ANTHONY GREGG | BUY | +8,646 | $3.47 | 12/12/2024 | 12/13/2024 |
| SCHABER CHRISTOPHER J | BUY | +45,000 | $3.31 | 12/12/2024 | 12/13/2024 |
| Straube Richard | BUY | +12,000 | $3.31 | 12/12/2024 | 12/13/2024 |
| Guarino Jonathan L. | BUY | +20,000 | $3.31 | 12/12/2024 | 12/13/2024 |
| Donini Oreola | BUY | +20,000 | $3.31 | 12/12/2024 | 12/13/2024 |
| Parks Diane L. | BUY | +8,646 | $3.47 | 12/12/2024 | 12/13/2024 |
| LAPOINTE ANTHONY GREGG | BUY | +38,136 | $0.59 | 12/15/2023 | 12/15/2023 |
| RUBIN ROBERT J. | BUY | +38,136 | $0.59 | 12/15/2023 | 12/15/2023 |
| Parks Diane L. | BUY | +38,136 | $0.59 | 12/15/2023 | 12/15/2023 |